VERVE-102: Could One Gene-Editing Infusion Replace Years of Cholesterol Treatment?
💡 Key Takeaways • VERVE-102 uses base editing to permanently disable PCSK9 in the liver.• Early data showed up to 88% reduction in PCSK9 and…
💡 Key Takeaways • VERVE-102 uses base editing to permanently disable PCSK9 in the liver.• Early data showed up to 88% reduction in PCSK9 and…